It’s been a very successful last few days for the team at Business Events Perth, with the organisation scoring two huge conference wins.
Thousands of the world’s brightest minds are set to gather in Perth in 2024 when the International Congress on Neuromuscular Diseases returns to Perth for the first time in over 50 years.
The congress is one of the leading global conferences on neuromuscular diseases, attracting thousands of delegates from around the world.
The event was first held in Perth in 1971, following the ground-breaking research by Western Australian Emeritus Professor Byron Kakulas, who showed that degenerated muscle could regenerate in quokkas.
This research eventually led to United States Food and Drug Administration approved treatments developed by the Perron Institute for Neurological and Translational Science for Duchenne muscular dystrophy, with application to other diseases.
Business Events Perth CEO Gareth Martin said Western Australia had put forward a competitive bid to the specialty group on neuromuscular diseases for the World Federation of Neurology to secure the congress for 2024.
“Our expertise in bidding for international business events, combined with Western Australia’s excellence in the field of neuroscience, ensured that Perth was the obvious choice to host the International Congress on Neuromuscular Diseases in 2024,” he said.
“As part of the bidding process, Western Australia presented itself as a premium destination to host business events, with a capital city filled with brand-new hotels and venues as well showing its ingenuity by collaborating with the local organising committee and industry to live stream its presentation to the globally-based decision-making committee.
“This innovation and collaboration meant Western Australia was highly competitive against other global destinations.”
Tourism Australia supported the bid to bring this event back Down Under through the Business Events Bid Fund Program.
Business Events Perth has also secured Australia’s largest life sciences conference, AusBiotech, to come to WA in 2022.
Martin said AusBiotech 2022 is expected to attract over 1000 delegates to Perth, as well as bring new commercial opportunities to the state’s biotechnology industry.
“Western Australia’s life science industry is one of the fastest growing in Australia, with the total economic contribution estimated to be $29.7 billion last year,” he said.
“The AusBiotech conference and Australia’s leading life sciences investment event will be held in our thriving state is an important opportunity to showcase Western Australia’s significant expertise in the biotech and life sciences sector, not only to the rest of Australia, but also to the world.”
AusBiotech will be held in Perth in October 2022 and is expected to attract researchers, developers, start-ups, investors, innovators, universities and corporates from all over Australia and around the world.
Running in conjunction with the conference is the Australia Biotech Invest & Partnering event, which will provide opportunities for local companies and professional service providers to connect with key stakeholders and investors.
Business Events Perth partnered with WA’s Department of Jobs, Tourism, Science and Innovation and the City of Perth to secure AusBiotech.
Featured image source: Business Events Perth